Nexalin Technology launched a virtual clinic to enhance patient treatment and data management for its HALO™ headset in clinical studies. Nexalin Technology, Inc. has announced the successful launch of ...

There is an explosion of innovation in drug development. In 2023, the FDA approved 55 novel drugs. There were five approved gene therapies for rare diseases, including the first-ever FDA-approved ...

ATLANTA, Georgia, USA, 3 June 2025 – In a comprehensive Genomic Press interview published today in Psychedelics, Dr. Deanna M. Kaplan reveals how her journey from journalism student to clinical ...

Clinical trials are critical to the future of the healthcare system. While already a well-established activity, clinical trial protocols and compliance are always evolving. This continual ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV) today announced the launch of One Home for Sites™, a new technology platform that acts as a single sign-on and a single dashboard for ...

Over 100 Invisalign® and iTero™-trained doctor educators from around the world spent 2 1/2 days immersed in deep-dive education workshops focused on Align’s latest innovations and clinical evidence ...

During this session, the panelists discussed how stakeholders in the clinical research market can leverage new technologies to better identify subjects, optimize trial conduct and reduce costs. For ...

Increasing costs, complexity, regulatory demands and decentralization of clinical trials are driving PE dealmakers to invest more in designers of clinical research technologies. Tech providers and ...

SHANGHAI, April 15, 2024 /PRNewswire/ -- The9 Limited (NCTY) ("The9"), an established Internet company, today announced that its investee WM Therapeutics Co., Ltd. (未名脑脑) ("WM Therapeutics") has ...

New integrations with industry leaders in EDC, eConsent, IRT/RTSM, eCOA, payments, and patient engagement expands Advarra's connected ecosystem, giving sponsors, CROs, and research sites secure, ...